Literature DB >> 6824168

The role of metabolism and protein binding in thiopental anesthesia.

P G Burch, D R Stanski.   

Abstract

The role of metabolism, relative to redistribution, in the termination of anesthesia was examined in patients receiving a single bolus iv injection of thiopental. Additionally, it was determined if nonlinear protein binding occurs immediately after the bolus iv injection of thiopental, possibly enhancing thiopental effect. Thiopental pharmacokinetics and protein binding were determined in 12 surgical patients with normal hepatic function. Using the pharmacokinetic equations listed in the appendix, plasma concentration over time data were used to quantitate the contribution of metabolism to the early decline of thiopental plasma concentrations after a single iv bolus administration. The fraction of thiopental loss from the central compartment due to metabolism was calculated to be 0.14 +/- 0.06 (mean +/- SD) at 1 min and 0.18 +/) 0.04 at 15 min. These data confirm that metabolism is far less important than distribution in the initial decline of blood and brain concentrations of thiopental, and, therefore, termination of thiopental anesthetic effect. The protein binding of thiopental from 0.5 to 15 min was found to be linear over a concentration range of 93 +/- 60 micrograms/ml to 6.9 +/- 0.62 micrograms/ml. Thus, concentration-dependent or nonlinear protein binding of thiopental after a single iv bolus administration could not be demonstrated and does not enhance thiopental anesthetic effect.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6824168     DOI: 10.1097/00000542-198302000-00008

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  12 in total

1.  Affinities of barbiturates for the GABA-receptor complex and A1 adenosine receptors: a possible explanation of their excitatory effects.

Authors:  M J Lohse; S Böser; K N Klotz; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

2.  Inhibition by anaesthetics of 14C-guanidinium flux through the voltage-gated sodium channel and the cation channel of the 5-HT3 receptor of N1E-115 neuroblastoma cells.

Authors:  M Barann; M Göthert; K Fink; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

3.  Atracurium, pharmacokinetics and metabolites.

Authors:  F Donati
Journal:  Can J Anaesth       Date:  1989-05       Impact factor: 5.063

4.  Extended blood collection period required to define distribution and elimination kinetics of propofol.

Authors:  G A Campbell; D J Morgan; K Kumar; D P Crankshaw
Journal:  Br J Clin Pharmacol       Date:  1988-08       Impact factor: 4.335

Review 5.  Pharmacodynamics and pharmacokinetics of thiopental.

Authors:  H Russo; F Bressolle
Journal:  Clin Pharmacokinet       Date:  1998-08       Impact factor: 6.447

6.  Pharmacokinetics of thiopental after single and multiple intravenous doses in critical care patients.

Authors:  H Russo; J Brès; M P Duboin; B Roquefeuil
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

7.  [Hemodynamic interferences between diltiazem and thiopental--experimental study in the pig].

Authors:  M Pierrot; M Blaise; S Hugon; F Bonnel; M Cupa
Journal:  Can Anaesth Soc J       Date:  1984-03

Review 8.  Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure.

Authors:  G Heinemeyer
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

9.  Thiopental bolus during carotid endarterectomy-rational drug therapy?

Authors:  J A Moffat; M J McDougall; D Brunet; F Saunders; E S Shelley; F W Cervenko; B Milne
Journal:  Can Anaesth Soc J       Date:  1983-11

10.  Variability of thiopental clearance in routine critical care patients.

Authors:  H Russo; J Brés; M P Duboin; B Roquefeuil
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.